Literature DB >> 1040464

Differences in susceptibility of Enterobacteriaceae and penicillin-resistant Staphylococcus aureus to tetracycline and minocycline.

C Candanoza, P D Ellner.   

Abstract

Two hundred strains of penicillin-resistant Staphylococcus aureus and 311 isolates of Enterobacteriaceae were compared for their susceptibility to tetracycline and minocycline. Thirteen and one-half percent of the staphylococcal isolates were resistant to tetracycline but susceptible to minocycline. Similarly, 24% of the enterobacterial isolates were found to be tetracycline resistant but susceptible to minocycline. Of a total of 511 recent clinical isolates, 14.5% were susceptible to minocycline but were tetracycline resistant.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1040464      PMCID: PMC429115          DOI: 10.1128/AAC.7.3.227

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice.

Authors:  M C Bach; O Gold; M Finland
Journal:  J Lab Clin Med       Date:  1973-05

2.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  Bacteriological evaluation of minocycline, a new tetracycline.

Authors:  J Klastersky; D Daneau
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

  4 in total
  1 in total

1.  In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima).

Authors:  N A Kuck
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.